ResMed Q4 2023 Earnings Report
Key Takeaways
ResMed Inc. reported a 23% increase in revenue to $1.1 billion for the fourth quarter of fiscal year 2023. Diluted earnings per share were $1.56, and non-GAAP diluted earnings per share were $1.60. The company's performance was driven by strong global demand for its cloud-connected flow generator devices, patient interfaces, and software solutions.
Revenue increased by 23% to $1.1 billion, reflecting strong growth in constant currency.
Diluted earnings per share (EPS) reached $1.56, while non-GAAP diluted EPS was $1.60.
Operating cash flow was $237.4 million for the quarter.
The company's software-as-a-service revenue increased by 34%.
ResMed
ResMed
ResMed Revenue by Segment
ResMed Revenue by Geographic Location
Forward Guidance
ResMed is focused on delivering therapy and digital health solutions to improve people's lives outside the hospital, aiming to help 250 million lives in 2025.